Travere Therapeutics, Inc. (RTRX) has 85 open-market insider trades by 15 insiders since 2012. The most active filer is Martin Shkreli.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Martin Shkreli | — | — | 35 | $20.3M | 2014-11-21 |
| Steve Aselage | Dir | — | 12 | $2.1M | 2020-11-06 |
| Laura Clague | CFO | — | 6 | $887K | 2020-11-25 |
| Eric M. Dube | CEO | — | 2 | $496K | 2020-09-21 |
| Neil F. McFarlane | COO | — | 3 | $492K | 2019-05-16 |
| Alvin Shih | VP | — | 3 | $423K | 2016-09-01 |
| Jeffrey A. Meckler | Dir | — | 3 | $350K | 2020-05-15 |
| Elizabeth E. Reed | VPSecretary | — | 5 | $302K | 2020-11-16 |
| William E. Rote | PresVP | — | 4 | $246K | 2020-11-16 |
| Jeffrey Paley | Dir | — | 1 | $246K | 2014-08-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Laura Clague | CFO | Sell | $175K | 2020-11-24 |
| William E. Rote | President & VP | Sell | $60K | 2020-11-16 |
| Elizabeth E. Reed | VP & Secretary | Sell | $60K | 2020-11-16 |
| Laura Clague | CFO | Sell | $180K | 2020-11-16 |
| William E. Rote | President & VP | Sell | $59K | 2020-11-13 |
| Laura Clague | CFO | Sell | $177K | 2020-11-13 |
Companies that share insiders with RTRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Steve Aselage | Director | Sell | $581K | 2020-11-05 |
| Peter Heerma | Chief Commercial Officer | Sell | $84K | 2020-10-02 |
| William E. Rote | President & R&D | Sell | $28K | 2020-09-23 |
| Noah L. Rosenberg | Chief Medical Officer | Sell | $14K | 2020-09-23 |
| William E. Rote | President & R&D | Sell | $28K | 2020-09-22 |
| Noah L. Rosenberg | Chief Medical Officer | Sell | $14K | 2020-09-22 |
| Eric M. Dube | CEO | Sell | $386K | 2020-09-21 |
| Steve Aselage | Director | Sell | $49K | 2020-08-05 |
| Noah L. Rosenberg | Chief Medical Officer | Sell | $18K | 2020-07-28 |